Untitled

Cancelled**This event has been cancelled. Our apologies for any inconvenience.**

HealthTrust presents…”Stop the Bleed: The Development & Implementation of an Anticoagulation Monitoring & Reversal Protocol”

Since the approval of direct oral anticoagulants (DOACs) for the prevention of stroke in patients with non-valvular atrial fibrillation and the prevention and treatment of venous thromboembolism (VTE), research has continued to delineate what other applications DOACs might have. Pharmacists may not be aware of updates to the indications, doses and applications for these medications. Recently, rivaroxaban has received FDA approval for two additional dose schedules and indications. Additionally, new evidence has been published on the use of apixaban to prevent VTE in patients with cancer. The presenter will share information and evidence associated with these new indications.

Learning Objectives for pharmacists  |  At the end of this session, participants should be able to:

1. Describe the anticoagulation recommendations of certain treatment guidelines
2. Recall evidence for reversal of anticoagulant medications
3. Compare and contrast clotting factor concentrates commonly used for anticoagulation reversal
4. Discuss the North Florida Regional Medical Center’s anticoagulation monitoring and reversal policy

Learning Objectives for pharmacy technicians  |  At the end of this session, participants should be able to:

1. Describe the different anticoagulants and reversal agents available
2. Discuss the evidence supporting reversal agents

Presenters:

Abigail Antigua, PharmD, BCCCP |   Advanced Clinical Pharmacist  |  North Florida Regional Medical Center

Kacee Barnett, PharmD, BCCCP  |  Advanced Clinical Pharmacist  |  North Florida Regional Medical Center

Target Audience:  Pharmacists & Pharmacist Technicians

Continuing Education Information:  1.0 contact hours approved for Pharmacists and Pharmacist Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-082-L04-P and 0863-9999-19-082-L04-T. The activity is pending approval for 1 hour (.1 CEUs) of continuing education credit to pharmacists and pharmacist technicians who attend the webinar and complete the online evaluation.

Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.

Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.

A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.